Grifols Expands Global Reach With New Treatment Facility

Verkkothe new plant further reflects grifols investment in europe and expands its current global capacity to meet rising demand for plasma medicines.

Verkkothe flagship grifols campus is a touchstone of grifols’ leadership in plasma therapeutics, producing about 40% of the company’s total medicinal output.

Verkkolocated in the va building at the umass chan medical school campus in worcester, mass. , grifols' new biomat usa donor center joins the.

Verkkothe transaction bolsters grifols’ standing as a global leader in fractionation capacity (20 million liters plasma/year) and operator of europe’s largest.